Navigation Links
Anadys Pharmaceuticals to Report Fourth Quarter and Year End 2008 Financial Results
Date:2/19/2009

SAN DIEGO, Feb. 19 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will report fourth quarter and year end 2008 financial results on Thursday, February 26, 2009, after the U.S. financial markets close.

Anadys will hold a conference call and webcast to discuss its fourth quarter and year end 2008 financial results and highlights and to provide an update on its development programs on Thursday, February 26, 2009 at 5:00 p.m. Eastern Standard Time. A live webcast of the call will be available online at www.anadyspharma.com. A telephone replay will also be available approximately one hour after completion of the call. To access the telephone replay, dial 888-286-8010 (domestic) or 617-801-6888 (international), passcode 93047283. The webcast and telephone replay will be available through March 12, 2009.

About Anadys

Anadys Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. For the treatment of chronic hepatitis C, the Company is developing two potentially complementary agents, ANA598, a non-nucleoside polymerase inhibitor and ANA773, an oral TLR7 agonist prodrug. The Company is also developing ANA773 for the treatment of cancer.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to Anadys' strategy, development programs, and ability to develop novel medicines in the areas of hepatitis C and oncology. Such forward-looking statements involve known and unknown risks, uncertainties and ot
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
2. Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study
3. Anadys Pharmaceuticals to Present at Bio Investor Forum
4. Anadys Pharmaceuticals to Present at BIO InvestorForum 2007
5. ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results
6. Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
7. Cadence Pharmaceuticals Completes $86.6 Million Private Placement of Common Stock
8. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook
9. Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug
10. Arena Pharmaceuticals Announces Initiation by Merck of Phase 2 Clinical Trial of Niacin Receptor Agonist
11. Frost & Sullivan: Australian Pharmaceuticals and Life Sciences IT Market Is Still Growing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... using technology developed at Case Western Reserve University,s ... of Engineering, has made available avatarsvirtual patientsto train ... and others training to evaluate speech-language disorders to ... on the trainee, because a diagnosis doesn,t have ... , Graduate students studying to become speech-language pathologists ...
(Date:6/18/2013)... The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) ... President’s Emergency Plan for AIDS Relief (PEPFAR) to mark ... in the global effort to eliminate pediatric HIV/AIDs. ... of June 2013, one million babies globally have been ... inception in 2003, EGPAF has been a key implementer ...
(Date:6/18/2013)... 2013 A new $119 million industry ... aquaculture industry is redefining the way consumers get their ... acclaimed personal culinary chefs on the Emerald Coast panhandle ... sustainable seafood and the promising industry of aquaculture. , ... Many consumers strive to fully partake in the effort, ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 New York magazine ... to its “Best Doctors” list, up from 129 last ... City. The new issue also lists 52 additional doctors who ... on a strategic growth trajectory. The “Best Doctors” issue, which ... the June 24 print issue and is available online at ...
(Date:6/18/2013)... to keep their scheduled medical appointments and their ... listens, explains things clearly and knows them as a ... suggests. , "If people feel their doctor really knows ... has their best interests at heart and may be ... Tabor E. Flickinger, M.D., M.P.H., a fellow in the ...
Breaking Medicine News(10 mins):Health News:SimuCase avatars advance speech-language pathology training 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 3Health News:New $119 Million Industry Swimming Up the East Coast 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 3Health News:Respect may be the key to stopping patient 'no shows' 2
... their new studies that the analysis of the placenta could ... from the University of Yale stated that they believe to ... by analysing and seeking out certain biological abnormalities present in ... disorder that affects a child's social learning and communication skills, ...
... for normal immune functioning found to be safe when ... - a new study finds. ,Visceral leishmaniasis, ... donovani, affects certain internal organs. People in tropical and ... this infectious disease through the bite of a sand ...
... 400 adult volunteers revealed compounds, which stimulate growth hormone ... ,The results of a study published at the ... of growth hormone work in adults to improve their ... ,The results will be presented by Dr. George ...
... new studies published in the Mayo Clinic Proceedings revealed ... use with the onset of cardiac syndromes.// ,‘Broken ... of breath mimics heart attack. ,The ... somewhat uncommon disorder first described in Japan 15 years ...
... giant Cipla has received the approval from the Food and ... anti-HIV/AIDS// drug Slamivudine," according to a posting on the FDA ... for ANDA is for an oral solution with strength of ... of drugs called as nucleoside reverse transcriptase inhibitors. It stops ...
... achievement, scientists at the Central Drug Research Institute (CDRI) here ... - a growing problem afflicting many across the country. ... that the existing anti-depression drugs. It is also free of ... told IANS. ,Elaborating on the drug, he said, ...
Cached Medicine News:Health News:Analysis of Placenta Helps In Diagnosis of Autism At Birth 2Health News:Lack of STAT1 -an Immune Protein, Pack Liver Infection Cure 2Health News:Lack of STAT1 -an Immune Protein, Pack Liver Infection Cure 3Health News:Growth Hormone Stimulants help to Combat Aging Symptoms 2Health News:Growth Hormone Stimulants help to Combat Aging Symptoms 3Health News:Sudden Opioid Withdrawal Results in ‘Broken Heart Syndrome 2
(Date:6/18/2013)... , June 18, 2013 New-generation ... being highly portable and lightweight. Simultaneously, circuitry is ... the processing speed to which it performs at. ... medical electronics and military equipment, such as cameras ... Omnetics, micro-circular and nano-circular connectors include custom cable ...
(Date:6/18/2013)... CAMPBELL, Calif. , June 18, 2013 /PRNewswire/ ... company focused on the development of next-generation atrial ... Patent No. 8295902 by the US Patent and ... patent encompasses low profile electrode assemblies for use ... endovascular ablation or other surgical procedures. ...
(Date:6/17/2013)... WASHINGTON , June 17, 2013 ... ) presented additional data today at ENDO 2013, ... demonstrating that tasimelteon can entrain (synchronize) both melatonin ... potential to reset the master body clock and ... Non-24-Hour Disorder (Non-24).  The SET (Safety and Efficacy ...
Breaking Medicine Technology:Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4
Sphincter of Oddi Solid State Catheter Adapter Cable for Polygraf ID...
... diagnosis of influenza A and ... due to the availability of ... of influenza using Clearview Exact ... lead to reduced hospital stays, ...
... A1c-Cellular is the first HbA1c control available ... the entire HbA1c procedure including the lysing ... is a ready-to-use liquid control with an ... closed-vial stability of six months when refrigerated. ...
...
Medicine Products: